You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BCR/ABL

Showing 26 - 50 of 1,180
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

3rd Line Therapy or More to Treat Adult CML- CP in Real World

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Oct 16, 2023

Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Plasma Cell Myeloma Trial in Detroit (The DISCO

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • The DISCO App
  • Usual Care
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 31, 2022

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +13 more
    • CMVpp65-A*0201 peptide vaccine
    • +2 more
    • Duarte, California
    • +4 more
    Jan 4, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

      Completed
      • Leukemia
      • No Intervention
      • Cambridge, Massachusetts
        Takeda
      Feb 28, 2023

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +9 more
      • Los Angeles, California
      • +5 more
      Jan 27, 2023

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

        Completed
        • Leukemia, Myelogenous, Chronic
        • CTTQ Dasatinib tablet
        • Sprycel Dasatinib tablet
        • Changchun, Jilin, China
          Affiliated Hospital of Changchun University of Traditional Chine
        Dec 7, 2022

        Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

        Recruiting
        • Recurrent Childhood Acute Myeloid Leukemia
        • +17 more
          • Miami, Florida
            Nicklaus Children's Hospital
          May 13, 2023

          Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

          Not yet recruiting
          • Chronic Myelogenous Leukemia
          • Houston, Texas
            The University of Texas MD Anderson Cancer Center
          Oct 12, 2023

          "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

          Not yet recruiting
          • Chronic Myeloid Leukemia, Chronic Phase
            • Sohag, Egypt
              Sohag University Hospital
            Sep 14, 2022

            Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

            Not yet recruiting
            • Tyrosine Kinase Inhibitors
            • Chronic Myeloid Leukemia
            • treatment of TKI in CML
            • Poitiers, France
              Chu Poitiers
            Feb 21, 2023

            Chronic Myeloid Leukemia Trial (Asciminib)

            Available
            • Chronic Myeloid Leukemia
            • (no location specified)
            Jan 17, 2023

            Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Rochester (Hyperbaric oxygen)

            Recruiting
            • Acute Myeloid Leukemia
            • +6 more
            • Hyperbaric oxygen
            • Rochester, New York
              Wilmot Cancer Institute, University of Rochester
            May 16, 2022

            TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

            Recruiting
            • Chronic Myeloid Leukemia
            • Pisa, Italy
            • +1 more
            Jan 4, 2022

            CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

            Recruiting
            • CML
            • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
            • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
              FUNDALEU
            Jun 29, 2023

            CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

            Recruiting
            • CML, Chronic Phase
            • CML, Accelerated Phase
            • HS-10382(Part 1: Dose escalation)
            • HS-10382(Part 2: Dose expansion)
            • Wuhan, Hubei, China
              Union Hospital affiliated to Tongji Medical College of Huazhong
            Jan 12, 2023

            Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

            Recruiting
            • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
            • Chronic Phase Chronic Myelogenous Leukemia
            • Text Message-Based Navigation Intervention
            • Survey Administration
            • Philadelphia, Pennsylvania
              Sidney Kimmel Cancer Center at Thomas Jefferson University
            Apr 7, 2022

            Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

            Completed
            • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
            • +14 more
            • Aldesleukin
            • +7 more
            • Houston, Texas
              M D Anderson Cancer Center
            Jul 31, 2022

            Ponatinib in CML Patients in Chronic Phase

            Recruiting
            • Chronic Myeloid Leukemia, Chronic Phase
            • Therapeutic drug monitoring
            • Molecular Response
            • Cagliari, Italy
            • +4 more
            Nov 3, 2023

            Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

            Active, not recruiting
            • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
            • +36 more
            • Buffalo, New York
              Roswell Park Cancer Institute
            Jan 23, 2023

            Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

            Not yet recruiting
            • Chronic Myeloid Leukemia
            • Treatment-free Remission
            • TFR(Treatment-Free Remission)
            • (no location specified)
            Jun 27, 2022